FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

American Pharmaceutical Ingredients Vardenafil HCl Recall

Vardenafil HCl USP (trihydrate) for prescription compounding, packaged in a) 5g (NDC 58…

American Pharmaceutical Ingredients LLC · Waterford, MI

Risk level
Class II
Reported by FDA
Feb 28, 2018
Recall ID
D-0533-2018
Check your lot numberHow we source this data

Summary

American Pharmaceutical Ingredients recalled Vardenafil HCl starting Feb 9, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0533-2018 on Feb 28, 2018. Reason: CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system. Status: Terminated.

Why it was recalled

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Product description

Vardenafil HCl USP (trihydrate) for prescription compounding, packaged in a) 5g (NDC 58597-8575-2); b) 100g (NDC 58597-8575-6);c) 500g (NDC 58597-8575-7); d) 1000g (NDC 58597-8575-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327

Lot numbers, UPCs & expiration codes

Lot #: a) 070717-2, Exp. 05/31/2020; b) 070717-1, Exp. 05/31/2020; c) 070717-1, Exp. 05/31/2020; d) 070717-1, Exp. 05/31/2020.

Where it was sold

Nationwide within USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0533-2018
Classification
Class II
Status
Terminated
Recall initiated
Feb 9, 2018
FDA report date
Feb 28, 2018
Quantity
10000 g
Recall type
Voluntary: Firm initiated
Recalling firm
American Pharmaceutical Ingredients LLC

Original FDA data

Every field from FDA enforcement report D-0533-2018, exactly as published.

Show all FDA fields
City
Waterford
State
MI
Status
Terminated
Country
United States
Event ID
79149
Address
6650 Highland Rd Ste 302
Code information
Lot #: a) 070717-2, Exp. 05/31/2020; b) 070717-1, Exp. 05/31/2020; c) 070717-1, Exp. 05/31/2020; d) 070717-1, Exp. 05/31/2020.
Postal code
48327-1665
Report date
Feb 28, 2018
Product type
Drugs
Recall number
D-0533-2018
Classification
Class II
Recalling firm
American Pharmaceutical Ingredients LLC
Product quantity
10000 g
Termination date
Dec 2, 2019
Reason for recall
CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Vardenafil HCl USP (trihydrate) for prescription compounding, packaged in a) 5g (NDC 58597-8575-2); b) 100g (NDC 58597-8575-6);c) 500g (NDC 58597-8575-7); d) 1000g (NDC 58597-8575-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327
Distribution pattern
Nationwide within USA.
Recall initiation date
Feb 9, 2018
Initial firm notification
Letter
Center classification date
Feb 22, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0533-2018, published Feb 28, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls